Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Buerger's disease].

M Chochola1, K Márová, A Linhart

  • 1II interní klinika kardiologie a angiologie 1 LF UK a VFN, Praha. miroslav.chochola@vfn.cz

Casopis Lekaru Ceskych
|June 8, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Role of Pulmonary Artery Wedge Pressure on the Incidence of Atrial Fibrillation and Atrial Tachycardias in Patients With Isolated Pre-capillary Pulmonary Hypertension.

Physiological research·2021
Same author

Standardising clinical outcomes measures for adult clinical trials in Fabry disease: A global Delphi consensus.

Molecular genetics and metabolism·2021
Same author

Long-term experience with implantable treprostinil pumps in pulmonary arterial hypertension.

Bratislavske lekarske listy·2020
Same author

Predictors of survival in patients with pulmonary hypertension and acute right heart failure.

Bratislavske lekarske listy·2020
Same author

Plasma osteopontin levels, but not its myocardial expression, reflect heart failure severity in recently diagnosed dilated cardiomyopathy.

Herz·2019
Same author

Plasma osteopontin levels in patients with dilated and hypertrophic cardiomyopathy.

Herz·2017
Same journal

The personality of professor Otakar Štark in the context of the development of medical genetics in Czechoslovakia in the years 1950-1990.

Casopis lekaru ceskych·2026
Same journal

Václav Náprstek, MD - a forgotten hero.

Casopis lekaru ceskych·2026
Same journal

Professor Otto Piffl, the First Full Professor of Otology and Rhinology at the German University in Prague, passed away 100 years ago.

Casopis lekaru ceskych·2026
Same journal

Ancient sanctuary of Eileithyia, goddess of childbirth, on the island of Paros (Greece).

Casopis lekaru ceskych·2026
Same journal

European Partnership for Personalised Medicine (EP PerMed).

Casopis lekaru ceskych·2026
Same journal

Periodontitis and type 2 diabetes.

Casopis lekaru ceskych·2026
See all related articles

Buerger's disease, also known as Thromboangiitis obliterans (TAO), is an inflammatory condition strongly linked to heavy tobacco use. Discontinuing smoking is the primary treatment, often preventing the need for amputation.

Area of Science:

  • Vascular Medicine
  • Inflammatory Diseases
  • Toxicology

Context:

  • Buerger's disease (Thromboangiitis obliterans--TAO) is a rare, nonatherosclerotic inflammatory condition affecting extremities.
  • It exhibits a strong association with heavy tobacco consumption, primarily in young male smokers.
  • Increasing prevalence in women and limited data on advanced therapies are noted.

Purpose:

  • To summarize the key characteristics, associations, and management principles of Buerger's disease.
  • To highlight the critical role of tobacco cessation in managing TAO.
  • To identify gaps in knowledge regarding therapeutic interventions.

Summary:

  • TAO is a segmental inflammatory vascular disease affecting small and medium-sized vessels, predominantly in the limbs.

Related Experiment Videos

  • Histopathology varies by disease stage, being most diagnostic during the acute phase.
  • The primary treatment is absolute tobacco cessation, which is highly effective in preventing amputation.

    • Impact:

    • Emphasizes tobacco use as the principal modifiable risk factor for TAO.
    • Highlights the effectiveness of smoking cessation in preventing severe outcomes like amputation.
    • Underscores the need for further research into novel treatment modalities for Buerger's disease.